The study revealed that the knockdown of CB1 and CB2 receptors suppressed the growth of HPV-positive HNSCC cells, whereas activation with CB1/CB2 agonists increased proliferation and migration and reduced apoptosis. Here, CNR1 is linked to head and neck squamous cell carcinoma.